Daito Pharmaceutical Co.,Ltd.

Tokyo Stock Exchange 4577.T

Daito Pharmaceutical Co.,Ltd. Operating Income for the year ending May 31, 2024: USD 24.75 M

Daito Pharmaceutical Co.,Ltd. Operating Income is USD 24.75 M for the year ending May 31, 2024, a -33.76% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.

Daito Pharmaceutical Co.,Ltd. Operating Income for the year ending May 31, 2023 was USD 37.37 M, a -26.59% change year over year.
Daito Pharmaceutical Co.,Ltd. Operating Income for the year ending May 31, 2022 was USD 50.90 M, a -5.59% change year over year.
Daito Pharmaceutical Co.,Ltd. Operating Income for the year ending May 31, 2021 was USD 53.91 M, a 8.50% change year over year.
Daito Pharmaceutical Co.,Ltd. Operating Income for the year ending May 31, 2020 was USD 49.69 M, a 18.35% change year over year.

Key data

Date	Operating Income	EBIT	EBITDA	Net Income

Tokyo Stock Exchange: 4577.T

Daito Pharmaceutical Co.,Ltd.

CEO	Hiroshi Matsumori
IPO Date	March 24, 2010
Location	Japan
Headquarters	326, Yokamachi
Employees	1,070
Sector	Healthcare
Industries Pharmaceuticals Automotive Parts Cleaning Supplies Consumer Packaged Goods Cosmetics Drugstores & Retail Pharmacies Eyewear Personal Care

Description

Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. The company offers various active pharmaceutical ingredients and intermediates, prescription drugs, OTC drugs, and home-delivery medicines; formulations in various forms, such as tablets, capsules, troches, granules, and powders; and contract manufacturing services for formulations of medicinal products to pharmaceutical companies. It also sells health food products. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.

Key trends

Past 5 years